|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Commentary |
1 The Beatson Institute for Cancer Research, CRC Beatson Laboratories, Glasgow,
G61 1BD, UK
2 Institute for Biomedical and Life Sciences, University of Glasgow, Glasgow,
G12 8QQ, UK
* Author for correspondence (e-mail: wkolch{at}beatson.gla.ac.uk )
Raf comprises a family of three kinases, A-Raf, B-Raf and Raf-1, which are best known as key regulators of the MEKMAPK/ERK cascade. This module is often perceived as a linear pathway in which ERK is the effector. However, recent advances have unveiled a role for Raf outside this established signalling unit. Current evidence, including gene-knockout studies in mice, suggests that there are ERK-independent functions of Raf kinases. Regulation of apoptosis is one area in which Raf may function independently of ERK, although its substrates remain to be identified. Other studies have suggested that Raf has kinase-independent functions and may act as a scaffold protein.
Key words: Raf, Apoptosis, ERK/MAPK, Knockout mice, Signal transduction
Related articles in JCS:
This article has been cited by other articles:
![]() |
J. Newbern, J. Zhong, R. S. Wickramasinghe, X. Li, Y. Wu, I. Samuels, N. Cherosky, J. C. Karlo, B. O'Loughlin, J. Wikenheiser, et al. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development PNAS, November 4, 2008; 105(44): 17115 - 17120. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Boutros, E. Chevet, and P. Metrakos Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer Pharmacol. Rev., September 1, 2008; 60(3): 261 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Galmiche, J. Fueller, A. Santel, G. Krohne, I. Wittig, A. Doye, M. Rolando, G. Flatau, E. Lemichez, and U. R. Rapp Isoform-specific Interaction of C-RAF with Mitochondria J. Biol. Chem., May 23, 2008; 283(21): 14857 - 14866. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. U. Alejandro and J. D. Johnson Inhibition of Raf-1 Alters Multiple Downstream Pathways to Induce Pancreatic -Cell Apoptosis J. Biol. Chem., January 25, 2008; 283(4): 2407 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. McKay and D. K. Morrison Caspase-dependent Cleavage Disrupts the ERK Cascade Scaffolding Function of KSR1 J. Biol. Chem., September 7, 2007; 282(36): 26225 - 26234. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Purcell, B. J. Wilkins, A. York, M. K. Saba-El-Leil, S. Meloche, J. Robbins, and J. D. Molkentin Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo PNAS, August 28, 2007; 104(35): 14074 - 14079. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, and C. Carter Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5 Cancer Res., December 15, 2006; 66(24): 11851 - 11858. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Panka, M. B. Atkins, and J. W. Mier Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin. Cancer Res., April 1, 2006; 12(7): 2371s - 2375s. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Rushworth, A. D. Hindley, E. O'Neill, and W. Kolch Regulation and role of raf-1/b-raf heterodimerization. Mol. Cell. Biol., March 1, 2006; 26(6): 2262 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Panka, W. Wang, M. B. Atkins, and J. W. Mier The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells Cancer Res., February 1, 2006; 66(3): 1611 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jin, Y. Zhuo, W. Guo, and J. Field p21-activated Kinase 1 (Pak1)-dependent Phosphorylation of Raf-1 Regulates Its Mitochondrial Localization, Phosphorylation of BAD, and Bcl-2 Association J. Biol. Chem., July 1, 2005; 280(26): 24698 - 24705. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Strumberg, H. Richly, R. A. Hilger, N. Schleucher, S. Korfee, M. Tewes, M. Faghih, E. Brendel, D. Voliotis, C. G. Haase, et al. Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors J. Clin. Oncol., February 10, 2005; 23(5): 965 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Shi and D. A. Andres Rit Contributes to Nerve Growth Factor-Induced Neuronal Differentiation via Activation of B-Raf-Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades Mol. Cell. Biol., January 15, 2005; 25(2): 830 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lee, J.-Y. Kim, and W. B. Anderson Src Tyrosine Kinase Inhibitor PP2 Markedly Enhances Ras-independent Activation of Raf-1 Protein Kinase by Phorbol Myristate Acetate and H2O2 J. Biol. Chem., November 19, 2004; 279(47): 48692 - 48701. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ding, R. Gros, I. D. Gray, R. Taussig, S. S. G. Ferguson, and R. D. Feldman Raf Kinase Activation of Adenylyl Cyclases: Isoform-Selective Regulation Mol. Pharmacol., October 1, 2004; 66(4): 921 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Spagnuolo, K. Galler, G. Schmalz, C. Cosentino, S. Rengo, and H. Schweikl Inhibition of Phosphatidylinositol 3-Kinase Amplifies TEGDMA-induced Apoptosis in Primary Human Pulp Cells J. Dent. Res., September 1, 2004; 83(9): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Spagnuolo, K. Galler, G. Schmalz, C. Cosentino, S. Rengo, and H. Schweikl Inhibition of Phosphatidylinositol 3-Kinase Amplifies TEGDMA-induced Apoptosis in Primary Human Pulp Cells Journal of Dental Research, September 1, 2004; 83(9): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, O. Gjoerup, and T. M. Roberts The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling PNAS, July 13, 2004; 101(28): 10296 - 10301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Major, R. Lepe, and R. H. Costa Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators Mol. Cell. Biol., April 1, 2004; 24(7): 2649 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamata, C. A. Pritchard, and A. D. Leavitt Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation Blood, April 1, 2004; 103(7): 2568 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. R. Thomson, J. D. Starkey, J. L. Page, A. D. Ealy, and S. E. Johnson Transforming Growth Factor {beta}1 Is Up-regulated by Activated Raf in Skeletal Myoblasts but Does Not Contribute to the Differentiation-defective Phenotype J. Biol. Chem., January 23, 2004; 279(4): 2528 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Khan and A. G. Watts Intravenous 2-Deoxy-D-Glucose Injection Rapidly Elevates Levels of the Phosphorylated Forms of p44/42 Mitogen-Activated Protein Kinases (Extracellularly Regulated Kinases 1/2) in Rat Hypothalamic Parvicellular Paraventricular Neurons Endocrinology, January 1, 2004; 145(1): 351 - 359. [Abstract] [Full Text] [PDF] |
||||